Abraxis Oncology® is the proprietary pharmaceuticals division of Abraxis BioScience, LLC, an integrated global bio-pharmaceutical company. Abraxis Oncology® is dedicated to the discovery and development of novel cancer therapies that target tumor biological pathways. Our focus is to challenge current standards and develop next-generation therapies that revolutionize the treatment of cancer.
Abraxis Oncology
200 Somerset Corporate Blvd.
Bridgewater, NJ
08807
USA
view on map
http://www.AbraxisOncology.com
investorrelations@abraxisbio.com
908.393.8220
Type:
Industry